PRIME movers: taking stock of the EMA’s scheme
Taking stock of one PRIME, of the EMA’s flagship market access initiatives.
X
PRIME movers: taking stock of the EMA’s scheme
https://pharmaphorum.com/views-and-analysis/ema-prime-movers-market-access/
ema
Bungled Brexit move would trigger public health crisis, warns EMA
Regulator could be crippled by staff exodus during relocation.
FDA and EMA reach milestone in sharing confidential information
New agreement is culmination of three years of work by FDA and EMA
EMA and FDA aim to slash Gaucher disease R&D costs
Proposals include multi-company trial.
Macron’s France: advancing towards a European vision for healthcare?
What will Macron’s government mean for healthcare in his country and Europe?
Ireland steps up bid for European Medicines Agency
Dublin the ‘natural home’ for EMA after Brexit
UK medicines agency set to lose lucrative EMA work post-Brexit
Agency already working on how to share post-Brexit workload.